Immune response modifier conjugates
US10472420B2 · kind B2 · utility
7Cited by
167References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 2015 |
| Grant date | Nov 12, 2019 |
| Priority date | — |
| Expiry date | Jan 20, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/2887
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides IRM conjugates that includes an IRM moiety and a second active moiety covalently linked to the IRM moiety in which the covalent link does not depend on UV irradiation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.